A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT06260163 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06260163
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-19
- Primary completion
- 2027-02-10
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.